Showing results (181-190 of 254) with videos related to

Sort By:
Pageof 26
Cancers|February 16, 2020
ABCG2 Overexpression Contributes to Pevonedistat ResistanceRishil J Kathawala, Claudia M Espitia, Trace M Jones, et al.
Primary Care Diabetes|November 29, 2025
The impact of pay-for-performance programs on hospitalization risks in subjects with type 1 diabetes mellitus: A nationwide cohort studyYun-Kai Yeh, Fu-Shun Yen, James Cheng-Chung Wei, et al.
Neuroimage|March 21, 2021
The acts of opening and closing the eyes are of importance for congenital blindness: Evidence from resting-state fMRIYi-Xuan Feng, Ren-Yuan Li, Wei Wei, et al.
Oncotarget|December 31, 2015
Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicinYi-Jun Wang, Yujian Huang, Nagaraju Anreddy, et al.
BMC Nephrology|April 15, 2024
Determinants of early chronic kidney disease in patients with recently diagnosed type 2 diabetes mellitus: a retrospective study from the Taiwan Diabetes RegistryYun-Kai Yeh, Kuan-Hung Lin, Wayne Huey-Herng Sheu, et al.
Phytokeys|August 2, 2026
Ophiorrhiza xinchengensis (Rubiaceae), a new species from Guangxi, ChinaGui-Yuan Wei, Jin-Yue Li, Rong Chen, et al.
International Journal of Oncology|March 15, 2014
Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistanceRishil J Kathawala, Jun-Jiang Chen, Yun-Kai Zhang, et al.
Journal of the American Heart Association|June 11, 2018
Prognostic Utility of Soluble TREM-1 in Predicting Mortality and Cardiovascular Events in Patients With Acute Myocardial InfarctionYun Kai Wang, Jia Ni Tang, Yun Li Shen, et al.
Cancers|February 27, 2020
Lipid-Saporin Nanoparticles for the Intracellular Delivery of Cytotoxic Protein to Overcome ABC Transporter-Mediated Multidrug Resistance In Vitro and In VivoGuan-Nan Zhang, Pranav Gupta, Ming Wang, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 28, 2018
Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer CellsPranav Gupta, Yun-Kai Zhang, Xiao-Yu Zhang, et al.
Pageof 26